Innate Pharma announces its participation to upcoming investor conferences and conference call for First half 2023 business update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in upcoming investor conferences, detailed below. In addition, the Company will hold a conference call on Thursday, September 14, 2023, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2023.

• Citi’s 18th Annual BioPharma Conference
• Event Date: September 6 – 7, Boston

• H.C. Wainwright 25th Annual Global Investment Conference
• Event Date: September 11 – 13, New-York

• Morgan Stanley 21st Annual Global Healthcare Conference
• Event Date: September 11 – 13, New-York

• First Half 2023 Financial Results and Business Update
• Event Date: September 14 – Conference call and Webcast

*****
Details for the First Half 2023 Business Update Virtual Event

Thursday, September 14, 2023, at 2 p.m. CEST / 8 a.m. EDT

The live webcast will be available at the following link: 
https://events.q4inc.com/attendee/859850812 

Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4E60903 

This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.

*****